Scientists affiliated with the Knight Initiative for Brain Resilience at Wu Tsai Neuro have discovered a surprising connection between brain cells involved in producing the insulation around nerve fibers, our sleep patterns, and neurodegenerative diseases such as multiple sclerosis (MS).
Hockey teams in losing startÂ
By MICHAEL MIYOBA
ZAMBIA national hockey teams’ dream to qualify for the 2024 Paris Olympic qualifiers suffered a major setback after starting the Olympic qualifiers taking place in South Africa with defeats.
The Women’s side was stunned 4-0 by Kenya who had dominated the match from the first quarter to win the Group B contest which was played at TUKS Hockey Stadium in Pretoria.
The men’s team led by coach Elvis Bwalya gave up a first half lead to lose 3-1 to Ghana, who couldn’t allow the bad weather in Pretoria to have a negative impact on their chase for the Olympic spot.
After a bad start yesterday, the men’s team will face Kenya in the second Group B game while the Golden Girls will take on Namibia today.
Meanwhile, women’s hockey team coach Floyd Chomba said the loss was unfortunate as they put up a good fight especially in the third and final quarter of the game.Â
Chomba said Zambia would not cry over the loss to Kenya but focus on the next match against Namibia.
“We played our first game. Unfortunately, we couldn’t get a win. Like we analysed Kenya came fast and I think we took time to get into the game. The first quarter is where we lost it all but from the third quarter and the last quarter the girls really did put up a good fight so what we can do right now is obviously, we can’t cry over spilt milk, we will look forward to the next game against Namibia and that game will decide if we are still in the race or not,” Chomba said.
Only the winners in both the men’s and women’s category will qualify for the Paris 2024 Olympic Games.Â
Texas lab unlocks keys to alcohol withdrawal headache
About 283 million people worldwide suffer from alcohol use disorder, a debilitating health challenge for which limited therapeutic options are available. The cost to society is estimated at greater than $2 trillion annually.
EPA testing shows the power of D-I-Y air filters to trap viruses
There is a low-cost way for you to protect yourself and reduce your risk of respiratory diseases such as flu, RSV, and COVID-19. Build yourself a Corsi-Rosenthal box (CR box) in 30 minutes with just $60 worth of common hardware store supplies.
Innovative antibody approach targets deep-seated cancer mutations
For too long, cancer treatment has been a double-edged sword—the very treatments designed to kill cancer cells often wrought havoc on healthy ones too.
How molecules in the zebrafish brain indicate it’s time to quit a fight
Two RIKEN neuroscientists have uncovered a molecular switch in the zebrafish brain that causes a fish to quit fighting against another zebrafish. This discovery could shed light on various mood disorders in people.
Updated menopause toolkit offers improved assessment and treatment
Care for women with menopausal health issues should improve globally following the release of an updated Monash University-led toolkit that guides health professionals around the world in assessing and treating them.
A wave theory for explaining neurochemical balance in the brain
In a new study, a group of researchers led by Dr. Joshua Goldberg from the Hebrew University describe a new kind of neurochemical wave in the brain. Their research, published in Nature Communications, unveils the existence of traveling waves of the neurochemical acetylcholine in the striatum, a region of the brain responsible for motivating actions and habitual behaviors.
Scientists isolate ‘pre-emerging’ bat coronavirus but also identify existing medication that potently neutralizes it
Repeated outbreaks of bat-derived coronaviruses among humans and other mammals have heightened the need for a broad range of therapeutics—monoclonal antibodies and antivirals—treatments that can come immediately “off-the-shelf” to address newly-emerging zoonotic threats.
Expert explains why a change is needed when talking about dementia
One of the challenges in addressing Alzheimer’s disease, dementia, cognitive impairment and aging is not related to the conditions themselves but rather the terminology. That’s according to Dr. Ronald Petersen, director of the Mayo Clinic Alzheimer’s Disease Research Center, who suggests a new framework for dementia nomenclature is needed.